Global Human Activin A market is expected to reach 15,456.8 thousand US$ by 2026; growing at a CAGR of 12.9% till 2026

In terms of volume, the Human Activin A Consumption was valued at 949.6 Mg in 2019 witnessing a CAGR of 12.4% from 2020 to 2026.

Activin A is a member of the TGF-β superfamily of cytokines, was originally identified as an inducer of follicle-stimulating hormone release, and it modulates the proliferation and differentiation of various target cells. Activin A is a disulfide-linked homodimer that binds to heteromeric complexes of type I and a type II serine-threonine kinase receptor. Activin A and its binding protein follistatin can be crucial in glucose homeostasis, as multifunctional proteins mediating inflammatory and anti-inflammatory effects. Human Activin A maintains the undifferentiated state of human embryonic stem cells and facilitates differentiation of human embryonic stem cells into definitive endoderm.

Top key players @ Ajinomoto, Thermo Fisher Scientific, Merck, STEMCELL, PeproTech, Bio-Techne, StemRD, Prospec, Proteintech Group, Enzo Biochem, Sino Biological, ReproCELL.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Get sample copy of this report @
https://www.infinitybusinessinsights.com/request_sample.php?id=496138

The increasing use of human activin A for renal damage in AAV patients is boosting the global human activin A market. According to the researches, measuring the levels of activin A protein in the urine can help clinicians identify patients with renal problems caused by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Activin A is known to control kidney development and to block regeneration of renal tubules after injury in adult kidneys. Moreover, increasing the use of human activin A in research activities would provide lucrative opportunities for the market in the coming years.

IL-4, GM-CSF, and Others in the type segment of the market scope, the application segment is further divided into Commercial Research and Academic Research, and the end-user segment is categorized into Duloxetine HCl and Others. The report covers the value of the global market by type, application, and end-user.

The market value IL-4 was XX thousand US$ in 2019, and it is expected to reach XX thousand US$ by 2026, growing at a CAGR of XX during 2020-2026. IL-4 is the dominant segment and accounted for approximately 47.59% of the market in 2019, due to the increase in clinical trials of IL-4 vaccine for the treatment of autoimmune diseases.

TABLE OF CONTENT:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst’s Viewpoints/Conclusions
15 Appendix

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:
Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering the services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.
We attain particular and niche demand of the industry while stabilize the quantum of standard with specified time and trace crucial movement at both the domestic and universal levels. The particular products and services provided by Infinity Business Insights cover vital technological, scientific and economic developments in industrial, pharmaceutical and high technology companies.

Contact Us:
Amit J
Sales Coordinator
+1-518-300-3575
amit@infinitybusinessinsights.com
https://mobile.twitter.com/IBInsightsLLP
https://facebook.com/Infinity-Business-Insights-352172809160429
https://www.linkedin.com/company/infinity-business-insights/

This release was published on openPR.